Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05522426 · ClinicalTrials.gov registry record · NA
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
A NA study of Facial Atrophy and Loss of Contour, sponsored by Syntr Health Technologies.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT05522426: Active NA study of Facial Atrophy and Loss of Contour, sponsored by Syntr Health Technologies.
NCT05522426 is a NA study of Facial Atrophy and Loss of Contour that is active but no longer recruiting, run by Syntr Health Technologies. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05522426, a NA study of Facial Atrophy and Loss of Contour, is active but no longer recruiting, sponsored by Syntr Health Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites.
Primary Outcome
Change from baseline in FACE-Q Satisfaction with questionnaire score for the treated regions
Conditions Studied
Interventions
- DEVICE SyntrFuge System
Study Locations (2)
California
- Newport Beach Site 1 - Newport
- Newport Beach Site 2 - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT05522426 still lists
NCT05522426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Facial Atrophy and Loss of Contour appearing as the primary indexed condition, and to 1 intervention - of which SyntrFuge System is the first listed.
NCT05522426 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05522426 about?
NCT05522426 is a clinical study titled "Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting". This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an inject...
What is the current status of trial NCT05522426?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-01. Estimated completion is 2025-12.
What conditions does trial NCT05522426 study?
This clinical trial studies the following conditions: Facial Atrophy and Loss of Contour.
What interventions are being tested in trial NCT05522426?
The interventions under investigation include: SyntrFuge System (DEVICE).
Who is sponsoring clinical trial NCT05522426?
This trial is sponsored by Syntr Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05522426 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05522426's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI